283 related articles for article (PubMed ID: 4303862)
21. [Comparison among single, double and triple drug regimens in retreatment. (the seventh series of the trial, B)].
Kekkaku; 1968 Jun; 43(6):199-207. PubMed ID: 5701828
[No Abstract] [Full Text] [Related]
22. The use of second line drugs in patients with drug resistance to standard tuberculostatics.
Zierski M
Dis Chest; 1968 Apr; 53(4):421-6. PubMed ID: 5652478
[No Abstract] [Full Text] [Related]
23. Treatment of tuberculosis.
Bates JH
Adv Intern Med; 1975; 20():1-21. PubMed ID: 46687
[No Abstract] [Full Text] [Related]
24. Chemotherapy of tuberculosis.
Lester W
Clin Notes Respir Dis; 1970; 9(2):3-13. PubMed ID: 4319281
[No Abstract] [Full Text] [Related]
25. [Certain aspects of new combinations of drugs for the treatment of drug-resistant tuberculosis].
Jancík E; Novák M; Jancíková M; Tousek J; Krátký J; Feitová S; Zelenka M
Bull Int Union Tuberc; 1968 Dec; 41():188-91. PubMed ID: 5710247
[No Abstract] [Full Text] [Related]
26. [Intravenous chemotherapy of pulmonary tuberculosis].
Ivaniuta OM
Vrach Delo; 1971 Jan; (1):84-7. PubMed ID: 4325153
[No Abstract] [Full Text] [Related]
27. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
[No Abstract] [Full Text] [Related]
28. Chronic tuberculosis in refractory patients--therapeutic aspects.
Foster-Carter AF
Respiration; 1969; 26():Suppl:76-81. PubMed ID: 5381385
[No Abstract] [Full Text] [Related]
29. [The course and results of treatment of pulmonary tuberculosis as a function of the dosage of Pyrazinamide].
Malinowska B; Pawlak F
Gruzlica; 1970; 38(6):531-5. PubMed ID: 4317029
[No Abstract] [Full Text] [Related]
30. RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
CORPE RF; BLALOCK FA; GROSS JH; GOLDHAMMER EJ
Am Rev Respir Dis; 1964 Dec; 90():957-60. PubMed ID: 14233802
[No Abstract] [Full Text] [Related]
31. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
SCHLESS JM; ALLISON RF; INGLIS RM; WHITE EF; TOPPERMAN S
Am Rev Respir Dis; 1965 May; 91():728-37. PubMed ID: 14280946
[No Abstract] [Full Text] [Related]
32. [Therapy of pulmonary tuberculosis in its current aspects].
Gartmann JC
Bibl Tuberc; 1965; 20():59-70. PubMed ID: 4291161
[No Abstract] [Full Text] [Related]
33. Clinical and bacteriological results with Myambutol.
Goldman S; Brzaković N; Muzikravić T
Antibiot Chemother; 1970; 16():239-56. PubMed ID: 4332036
[No Abstract] [Full Text] [Related]
34. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
Zunić D
Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
[No Abstract] [Full Text] [Related]
35. [Autonomic drug therapy with delayed action drugs in pulmonary tuberculosis (chronic-drug therapy resistant patients, without immediate surgical possibilities)].
Bethlem N; Mendes W
Hospital (Rio J); 1968 Jul; 74(1):1-5. PubMed ID: 5305552
[No Abstract] [Full Text] [Related]
36. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis].
Aoyagi T; Fukuhara Y; Hondo G; Matsumiya T; Murata A
Kekkaku; 1970 Jan; 45(1):27-36. PubMed ID: 5416951
[No Abstract] [Full Text] [Related]
37. [Bacterial resistance tests against secondary antitubercular agents--reliability of the routine methods].
Tsukamura M
Iryo; 1966 Mar; 20(3):241-50. PubMed ID: 5964831
[No Abstract] [Full Text] [Related]
38. [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
Tsukamura M
Kekkaku; 1971 Oct; 46(10):405-8. PubMed ID: 4112456
[No Abstract] [Full Text] [Related]
39. [Evolution of antibiograms of bacilli persisting under treatment in the sanatorium].
Marion L
Rev Tuberc Pneumol (Paris); 1967; 31(6):785-808. PubMed ID: 4317451
[No Abstract] [Full Text] [Related]
40. [Effect and toxicity on the combined use of pyrazinamide, ethionamide and kanamycin in the retreatment of pulmonary tuberculosis (author's transl)].
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):199-200. PubMed ID: 555425
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
